SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001753926-24-000285
Filing Date
2024-02-13
Accepted
2024-02-13 16:27:08
Documents
1
Group Members
3I MANAGEMENT LLCMAIER JOSHUA TARLOW

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g084022_13ga.htm SC 13G/A 62664
  Complete submission text file 0001753926-24-000285.txt   64616
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Subject) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-83146 | Film No.: 24626447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 140 BROADWAY 38TH FLOOR NEW YORK NY 10005
Business Address 874 WALKER ROAD SUITE C DOVER DE 19904 (646) 845-0040
3i, LP (Filed by) CIK: 0001841619 (see all company filings)

IRS No.: 843800874 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A